Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) and electrophilic toxins are highly reactive chemical entities that induce cellular damage through oxidative and electrophilic stress (NIH, 2023). ROS, such as superoxide and hydrogen peroxide, are primarily byproducts of aerobic metabolism, while electrophilic toxins are electron-deficient molecules that can be endogenous metabolites or environmental pollutants (PubMed, 2007). While they serve as critical signaling molecules at physiological levels, their accumulation leads to the damage of DNA, proteins, and lipids, contributing to the pathogenesis of cancer, neurodegeneration, and cardiovascular diseases (StatPear}
Drugs interact with these species through direct chemical scavenging and neutralization, enzymatic degradation of radicals (e.g., superoxide dismutase mimetics), or by activating the Nrf2-Keap1 signaling pathway to upregulate endogenous antioxidant and phase II detoxification enzymes (Nature Reviews Drug Discovery, 2014).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species and electrophilic toxins (ROS/Electrophiles).